Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-20-002965.pdf
0001179110-20-002965.rtf
0001179110-20-002965.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-20-002966.pdf
0001179110-20-002966.rtf
0001179110-20-002966.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001179110-20-001761.pdf
0001179110-20-001761.rtf
0001179110-20-001761.xls
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0000080255-20-001272.pdf
0000080255-20-001272.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-20-000750.pdf
0001558370-20-000750.rtf
0001558370-20-000750.xls
EX-101.SCH - EX-101.SCH
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-20-000784.pdf
0001558370-20-000784.rtf
0001558370-20-000784.xls
EX-101.SCH - EX-101.SCH
S-8

Securities offered to employees pursuant to employee benefit plans

 View HTML
0001558370-20-000787.pdf
0001558370-20-000787.rtf
0001558370-20-000787.xls
S-3ASR

S-3ASR

 View HTML
0001558370-20-000789.pdf
0001558370-20-000789.rtf
0001558370-20-000789.xls
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0001104659-20-018026.pdf
0001104659-20-018026.rtf
0001104659-20-018026.xls
SC 13G/A

An amendment to the SC 13G filing

 View HTML
0000315066-20-000847.pdf
0000315066-20-000847.rtf